Overview

Effects of Fish Oil and Colesevelam (STAIR7007)

Status:
Active, not recruiting

Trial end date:
2021-07-30

Target enrollment:

Participant gender:

Summary

If treatment of colesevelam, fish oil in conjunction with ezetimibe, will lead to further reduction in plasma plant sterol levels in sitosterolemia patients. We hypothesize that treatments with fish oil, colesevelam and ezetimibe will maximize decrease in plasma concentrations of sitosterol and other plant sterols in sitosterolemia patients.

Phase:

N/A

Details

Lead Sponsor:

University of Manitoba

Treatments:

Colesevelam Hydrochloride